Trial Profile

Phase 1/2 trial of WT1 Cancer Vaccine in patients with multiple myeloma

Status: Recruiting

Phase of Trial: Phase I/II

Latest Information Update: 03 Mar 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Galinpepimut S (Primary)
Indications Multiple myeloma
Focus Therapeutic Use
Sponsors Sellas Life Sciences Group

Most Recent Events

01 Mar 2017 Updated positive Results published in a Sellas Life Sciences Group media release.
13 Oct 2016 Interim results published in the Sellas Life Sciences Media Release
15 Jan 2016 New trial record

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com